非骨科就诊增加骨关节炎患者阿片类药物暴露:单中心分析
这项单中心回顾性研究分析了2013至2018年间9625张骨关节炎阿片类处方,发现非骨科医生开具了92%的处方,且每人处方数、剂量和续方次数均高于骨科医生。非骨科就诊与高剂量处方风险增加相关,提示需多学科协作以减少不必要的阿片暴露。
要点
- 非骨科医生开具了92%的骨关节炎阿片处方,骨科医生仅占8%。
- 非骨科医生每人处方数、剂量和续方次数均显著高于骨科医生(P<.001)。
- 非骨科就诊与处方剂量≥50 MME/d(OR 5.81)和≥90 MME/d(OR 18.2)风险增加相关。
核心结论
- 骨关节炎的阿片类药物处方大多由非骨科医生开具,其处方率、剂量和续方次数均高于骨科医生。
- 骨关节炎作为常见病,需要多学科共同关注以减少不必要的阿片暴露和关节置换术后的潜在并发症。
研究设计与样本
- 单中心回顾性病历审查,纳入2013至2018年间因骨关节炎接受门诊阿片类处方的未使用过阿片类药物的成年患者。
- 排除既往有手术史或阿片类处方史的患者,采用独立t检验和方差分析比较不同提供者的处方特征。
主要发现
- 共识别9625张阿片类处方,非骨科提供者占92%,骨科医生占8%。
- 处方数量最多的是内科医生(37.1%)和家庭医学医生(36.0%)。
- 非骨科医生每人处方数、剂量和续方次数均更高(P < .001)。
- 非骨科就诊与处方剂量≥50 MME/d风险增加相关(OR 5.81,95%CI 4.35-7.81,P < .001)。
- 非骨科就诊与处方剂量≥90 MME/d风险增加相关(OR 18.2,95%CI 4.43-35.70,P < .001)。
临床怎么用
- 骨科医生应关注骨关节炎患者的阿片类药物使用史,尤其是来自非骨科就诊的高剂量处方。
- 多学科协作有助于减少骨关节炎患者不必要的阿片暴露,降低关节置换术后的潜在并发症风险。
局限性
- 本研究为单中心回顾性分析,结果可能受机构处方习惯影响。
- 仅纳入未使用过阿片类药物的患者,可能限制结论的外推性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There has been little-to-no evidence to support the use of opioid analgesia as a treatment modality for osteoarthritis (OA). Chronic opioid use has been associated with peri-operative and post-operative complications with joint reconstruction. The purpose of this study is to compare opioid-prescribing habits for OA between orthopedic and non-orthopedic physicians to identify encounters that increase opioid exposure. METHODS: A retrospective chart review was performed on opioid-naive adult patients with outpatient opioid prescriptions for OA at a single academic institution between 2013 and 2018. Patients with prior surgery or opioid prescriptions were excluded. Independent t-tests and analysis of variance were used to compare prescription characteristics among providers. RESULTS: A total of 9625 opioid prescriptions were identified. Non-orthopedic providers account for 92% of prescriptions vs 8% by orthopedic surgeons. The greatest number of prescriptions is written by Internal Medicine (37.1%) and Family Medicine physicians (36.0%). Non-orthopedic physicians prescribe a greater number of prescriptions per patient, dosages, and refills (P < .001 for all). Non-orthopedic encounters are associated with increased risk for prescription dosages ≥50 MME/d (odds ratio 5.81, 95% confidence interval 4.35-7.81, P < .001) and 90 MME/d (odds ratio 18.2, 95% confidence interval 4.43-35.70, P < .001). CONCLUSION: The majority of opioid prescriptions for OA are written by non-orthopedic providers, with higher prescription rates, dosages, and more refills than orthopedic surgeons. OA is a common condition that will benefit from multi-disciplinary awareness to minimize unnecessary opioid exposure and reduce potential complications with joint arthroplasty.
引用
- Johnson CA, Goodloe JB, Durante EC, et al. Non-Orthopedic Encounters Increase Opioid Exposure in Joint Osteoarthritis: A Single-Institution Analysis. J Arthroplasty. 2020. PMID: 32444234. doi:10.1016/j.arth.2020.04.076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。